ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,544.59
      -0.78%
      US Tech 100
      19,119.60
      -0.31%
      Dow Jones
      40,665.02
      -1.29%
      Brent Oil
      84.245
      0.20%
      Bitcoin
      63,732.77
      -0.37%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BioCryst Pharmaceuticals Inc (BCRX)

      7. BioCryst Pharmaceuticals Inc (BCRX) Financials

      BioCryst Pharmaceuticals Inc

      BioCryst Pharmaceuticals Inc (BCRX)

      NASDAQ
      7.05
      -0.22
      (-3.03%)
      Closed July 18 4:00PM
      Delayed by 15 minutes
      7.05
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      BioCryst Pharmaceuticals Inc Financial Summary

      The current BCRX market cap is 1.45B. The company's latest EPS is USD -1.0977 and P/E is -6.42.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 68.78M82.49M86.74M93.4M92.76M
      Operating Income -28.42M-20.7M-19.26M-42.67M-14.49M
      Net Income -53.33M-75.33M-36.15M-61.73M-35.38M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 48.84M17.81M157.17M270.83M331.41M
      Operating Income -99.46M-174.76M-177.72M-148.44M-103.71M
      Net Income -108.9M-182.81M-184.06M-247.12M-226.54M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 509.74M529.89M522.92M516.96M467.89M
      Total Liabilities 838.02M918.6M933.91M972.49M944.06M
      Total Equity -328.29M-388.71M-410.99M-455.53M-476.17M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 175.28M334.72M588.15M550M516.96M
      Total Liabilities 137.03M353.98M695.14M844.6M972.49M
      Total Equity 38.25M-19.26M-106.99M-294.6M-455.53M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -47.51M-66.33M-86.22M-95.14M-53.68M
      Investing -107.11M-126.14M-103.03M-131.5M28.76M
      Financing 5.08M34.43M35.66M32.49M-1.05M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -89.58M-137.22M-142.16M-161.85M-95.14M
      Investing 77.93M-6.86M15.8M-128.24M-131.5M
      Financing 99.1M302.7M359.67M88.03M32.49M

      Stats and Ratios

      Market Cap 1.45B
      Price to Earnings Ratio -6.42
      Price to Sales Ratio 4.39
      Price to Cash Ratio 13.15
      Price to Book Ratio -3.19
      Dividend Yield -

      Share Statistics

      Shares Outstanding 206.38M
      Average Volume (1 week) 3.18M
      Average Volume (1 Month) 3.39M
      52 Week Change -2.62%
      52 Week High 7.95
      52 Week Low 4.03
      Spread (Intraday) 1.68 (21.32%)

      Company Info

      Company Name BioCryst Pharmaceuticals Inc
      Address 2711 centerville road
      wilmington, delaware 19808
      Website https://www.biocryst.com
      Industry biological pds,ex diagnstics (2836)